Radionuclide Cancer Risk Coefficient (RCRC) Panel Meeting

Radionuclide Cancer Risk Coefficient (RCRC) Panel Meeting

Radiomics: A Tool for Predicting Tumor Response in Head and Neck Cancer PatientsПодробнее

Radiomics: A Tool for Predicting Tumor Response in Head and Neck Cancer Patients

Real Questions | Radiation Dose | UCLA RadiologyПодробнее

Real Questions | Radiation Dose | UCLA Radiology

Radiating Kidney Cancer Cells Into SubmissionПодробнее

Radiating Kidney Cancer Cells Into Submission

Radiologic Tests for Lung CancerПодробнее

Radiologic Tests for Lung Cancer

Fox Chase's Radiation Oncology Residency ProgramПодробнее

Fox Chase's Radiation Oncology Residency Program

Dr. Klopp on a Comparison of Standard Radiation to IMRT in Gynecologic MalignanciesПодробнее

Dr. Klopp on a Comparison of Standard Radiation to IMRT in Gynecologic Malignancies

2023 Virtual Symposium: Risk of Cancer from Medical ImagingПодробнее

2023 Virtual Symposium: Risk of Cancer from Medical Imaging

Radionuclide Cancer Risk Coefficients Review Panel MeetingПодробнее

Radionuclide Cancer Risk Coefficients Review Panel Meeting

Communication Curriculum for Radiology Residents: Radiation Risk Part 1Подробнее

Communication Curriculum for Radiology Residents: Radiation Risk Part 1

HCC: Role of Radiotherapy and Measuring ResponseПодробнее

HCC: Role of Radiotherapy and Measuring Response

International Conference on Advances in Radiation Oncology (ICARO2) - TrailerПодробнее

International Conference on Advances in Radiation Oncology (ICARO2) - Trailer

GRACEcast-059_Lung-Cancer_Expert Round Table - Ambiguous Imaging Results After Chemo/RadiationПодробнее

GRACEcast-059_Lung-Cancer_Expert Round Table - Ambiguous Imaging Results After Chemo/Radiation

Radiation Oncology II - Providence Cancer CenterПодробнее

Radiation Oncology II - Providence Cancer Center

Should prior X-ray or CT radiation dose influence scan prescriptions?Подробнее

Should prior X-ray or CT radiation dose influence scan prescriptions?

Radioactivity After Radiation TherapyПодробнее

Radioactivity After Radiation Therapy

Targeting cancer through new radiotherapy-drug combinationsПодробнее

Targeting cancer through new radiotherapy-drug combinations

Inhibiting cancer cells using NMR, by Dr. Andrew Byrd (National Cancer Institute)Подробнее

Inhibiting cancer cells using NMR, by Dr. Andrew Byrd (National Cancer Institute)

RMP Rounds | Liver Cancer Radiation Therapy: Ready for Prime Time?Подробнее

RMP Rounds | Liver Cancer Radiation Therapy: Ready for Prime Time?